Log In
Print
BCIQ
Print
Print this Print this
 

ME-344 (formerly NV-344)

  Manage Alerts
Collapse Summary General Information
Company MEI Pharma Inc.
DescriptionIsoflavone-derived mitochondrial inhibitor
Molecular Target Mammalian target of rapamycin complex 1 (mTORC1) ; Mammalian target of rapamycin complex 2 (mTORC2)
Mechanism of ActionMitochondrial inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat refractory solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today